Check out our most popular compounded medications! Get Started
Dashboard
Formulas

Clonidine HCl 430 µg Slow Release Capsules

FDA-approved generic
Dose form
Slow Release Capsules
Active ingredients
Clonidine Hydrochloride
For prescribers
Prescription details
RxThis formula
Dose formSee below
Quantity____
SigAs directed by prescriber
Refills____
PharmacyBayview Pharmacy, Warwick RI, NCPDP 4106882
Copy prescription detailsOrder form
Controlled substance: e-prescribe (EPCS) from your EHR. Faxed and phoned prescriptions cannot be accepted for this preparation.
Send it from your EHR, or fax to (401) 284-4506. How to e-prescribe this formula
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
To prescribe, you must be a verified prescriber.
To prescribe, you must be in a state where we hold an active out-of-state pharmacy license.
Starting at
Fill my prescription
Fill my prescription
Requires a prescription from your own provider. Bayview is a pharmacy and does not prescribe.
Ships within 1 to 2 business days after pharmacist verification
HSA and FSA eligible
Check if we ship to your state
No prescription yet?

Get a sheet with everything your doctor needs to prescribe this and send it to Bayview.

Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.

For prescribersSign in for prescription details and order forms.
Compounded preparations are prepared by Bayview pursuant to a prescription for an individual patient. They are not FDA-approved and have not been evaluated by FDA for safety or effectiveness.
Clonidine Hydrochloride
Slow Release Capsules
653f24359ce9c3fa3471096e
Service area

Can we ship this formula to your state?

Bayview fills prescriptions for patients in Connecticut, Florida, Maine, Massachusetts, New Hampshire, New Jersey, Pennsylvania and Rhode Island. New York patients are served on a limited basis while nonresident pharmacy registration is pending.

Check your state

Available in

Tap a state to check it.

Our current service area

Currently licensed Limited basis, registration pending Not available for this formula Not currently licensed

Select a state on the map or use the checker.

Prepared to a prescriber's order for one patient. Not FDA-approved.

This formulation

This is a compounded slow release capsule containing clonidine hydrochloride, prepared to a prescriber's order for one patient. Compounded preparations are not FDA-approved.

FDA product listings

These listings cover every salt or ester form of each drug in the FDA National Drug Code Directory.

FDA-approved products containing clonidine are listed in tablet, patch, injection, solution and suspension forms. No finished clonidine product of any kind is listed in capsule form.

Storage category and dating

This is a solid, nonaqueous dose form. Under USP <795>, nonaqueous preparations carry longer default beyond-use dates than water-containing ones. The date printed on the label is the one to follow.

Sources

Why prescribers order this

Compounded drugs are not FDA-approved. This means that FDA does not review these drugs to evaluate their safety, effectiveness, or quality before they reach patients.

Clonidine is a centrally acting alpha-2 agonist blood pressure medicine that compounding pharmacies prepare as oral liquids, capsules, topical gels and other forms.

About this ingredient

Clonidine is a centrally acting alpha-2 adrenergic agonist. It stimulates alpha-adrenoreceptors in the brain stem, which lowers the nervous system signals that tighten blood vessels and speed the heart, so blood pressure and heart rate fall. Manufactured products include clonidine hydrochloride tablets, Qlonilik oral solution, the Catapres-TTS weekly transdermal patch and Nexiclon XR extended-release tablets, all FDA-approved for hypertension; extended-release tablets and Onyda XR extended-release suspension approved for ADHD in children; and an epidural injection (Duraclon and generics) approved for severe cancer pain as an adjunct to opioids. A prescriber may order clonidine compounded when a patient needs a strength or dosage form that is not manufactured, cannot swallow tablets, or needs clonidine combined with another ingredient in one preparation. Compounded clonidine preparations are not FDA-approved and require a prescription.

Safety and interactions

Oral and transdermal clonidine carry no boxed warning. The epidural injection carries a boxed warning that it is not recommended for obstetrical, postpartum or perioperative pain because of the risk of severe low blood pressure and slow heart rate. For every form, the most important warning is about stopping suddenly: abrupt discontinuation can cause nervousness, headache and a rapid rise in blood pressure, so the label advises tapering over several days, especially at higher doses or with beta-blockers. Clonidine adds to the sedating effect of alcohol, barbiturates and other sedatives. Tricyclic antidepressants may blunt its blood pressure effect. With digoxin, beta-blockers, diltiazem or verapamil, heart rate should be monitored; severe slow heart rate needing a pacemaker has been reported with diltiazem or verapamil. People allergic to clonidine should not use it. The label says to use it in pregnancy only if clearly needed; it crosses the placenta. Clonidine passes into breast milk, and other blood pressure medicines are generally preferred while nursing a newborn. Common side effects are dry mouth, drowsiness, dizziness and constipation. If a side effect is severe or does not go away, or you faint or notice a slow or irregular heartbeat, talk to your prescriber or pharmacist.

Clonidine is a centrally acting alpha-2 adrenergic and imidazoline receptor agonist that reduces sympathetic outflow, lowering peripheral and renal vascular resistance, heart rate and blood pressure; in the spinal dorsal horn it reduces nociceptive transmission, which underlies epidural use. Oral absolute bioavailability is 70 to 80 percent with peak levels at 1 to 3 hours; the transdermal system delivers about 60 percent bioavailability over 7 days with therapeutic levels after 2 to 3 days. Protein binding is 20 to 40 percent. Elimination half-life is 12 to 16 hours, rising to about 41 hours in severe renal impairment; roughly half of an absorbed dose is metabolized hepatically and 40 to 60 percent is excreted unchanged in urine. Labeled indications: hypertension (Catapres-TTS, clonidine hydrochloride tablets), ADHD in children (the extended-release tablets labeled for ADHD and Onyda XR extended-release suspension; Nexiclon XR extended-release tablets are a hypertension product), and severe cancer pain unrelieved by opioids (epidural clonidine, Duraclon). Prescribers have ordered clonidine off-label for opioid, alcohol and benzodiazepine withdrawal, hot flashes, restless legs and migraine prophylaxis (StatPearls); no clonidine label lists Tourette tics, though StatPearls describes that use. Dosing and any taper are per prescriber; formulations are not interchangeable milligram for milligram. Monitor blood pressure and heart rate, screen for depression, and plan a gradual taper. Clonidine is not a controlled substance.

Sources

Using and storing

How it is used

Swallow the capsule whole with fluid. Do not crush, chew, divide or open it, and do not dissolve it in liquid, because that can release the full dose at once. Take it at the same times each day as your label directs. Slow release forms are not meant for feeding tubes; ask your pharmacist if you need a different form.

Storing it

These are nonaqueous capsules, so a USP <795> default beyond-use date of up to 180 days usually applies. Store in a closed container at room temperature, away from heat, moisture and direct light, and out of reach of children. Discard after the beyond-use date on the label.

Sources

Prescribing and ordering FAQs

Formula Information

A small arrow pointing down

Drug Interactions

A small arrow pointing down

How Does it Work

A small arrow pointing down

Frequently Asked Questions

A small arrow pointing down

About this compounded preparation

This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.

A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.

Formulas and/or material listed are not to be interpreted as a promise, guarantee or claim of therapeutic efficacy or safety. The information contained herein is not intended to replace or substitute for conventional medical care, or encourage its abandonment. Every patient is unique, and formulas should be adjusted to meet their individual needs.

No compounded medications are reviewed by the FDA for safety or efficacy.
For prescribers

How to e-prescribe this formula

Controlled substance: e-prescribe only (EPCS). Faxed, phoned, and handwritten prescriptions cannot be filled. Rhode Island law (R.I. Gen. Laws § 21-28-3.18) requires Schedule II to V prescriptions to be transmitted electronically.
1

Find Bayview in your EHR's pharmacy directory

Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.

NCPDP4106882NPI1750455143Address3844 Post Rd, Warwick, RI 02886Phone(401) 284-4505Fax(401) 284-4506
2

Enter the formula as a compound

Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.

Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.

3

Copy the prescription details

RxFormula name
Dose formDose form
Quantity________
SigAs directed by prescriber
Refills____
PharmacyBayview Pharmacy, Warwick RI, NCPDP 4106882
Copy prescription details

Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.

4

Send it

Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.

Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.

Do not use Notes to Pharmacy for the formula. Some EHRs keep that field internal and never transmit it. A prescription that arrives without the formula is delayed while we call your office.

Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.

Clonidine HCl 430 µg Slow Release Capsules
Slow Release Capsules
controlled

Take 1 capsule by mouth

Once daily